Kimberly Clark CORP 8-K filings

Kimberly-Clark announced preliminary third quarter 2026 financial data, indicating a slight decrease in net sales and organic growth compared to the prior year, but reaffirmed its full-year 2026 outlook for Adjusted Operating Profit and Adjusted Earnings per Share.

Kimberly-Clark announced the successful solicitation of consents for Kenvue notes, paving the way for its acquisition and the restructuring of Kenvue's debt.

Kimberly-Clark Corporation announced the departure of its President and Chief Operating Officer, Russell Torres, effective November 2, 2026, as he seeks other opportunities.

Kimberly-Clark's pro forma financials detail the anticipated financial standing post-acquisition of Kenvue, revealing combined assets of $71.5 billion and significant goodwill.

Kimberly-Clark announced second quarter 2026 results with net sales of $4.2 billion, driven by innovation and productivity, while updating its 2026 outlook.

Kimberly-Clark Corporation held its 2026 Annual Meeting of Stockholders, where directors were elected, auditors ratified, and executive compensation approved, though a proposal for an independent Board Chair was not approved.

Kimberly-Clark announced first quarter 2026 results, showing net sales growth and reaffirming its full-year outlook, driven by innovation and productivity.

Kimberly-Clark and Kenvue shareholders overwhelmingly approved all proposals for Kimberly-Clark's acquisition of Kenvue, moving closer to creating a global health and wellness leader.

Kimberly-Clark reported strong fourth-quarter and full-year 2025 results, driven by its transformation strategy and anticipating further momentum from the Kenvue acquisition.

Kimberly-Clark Corporation filed an 8-K to supplement its joint proxy statement/prospectus regarding its merger with Kenvue Inc., addressing multiple stockholder lawsuits alleging material omissions.

Kimberly-Clark Corporation has recast its 2024 financial statements to reflect the International Family Care and Professional (IFP) segment as discontinued operations following a joint venture agreement with Suzano S.A.

Kimberly-Clark Corporation announced the departure of Chief Digital and Technology Officer Zackery Hicks, effective March 31, 2026.

Kimberly-Clark Corporation announced an agreement to acquire Kenvue Inc. in a cash and stock transaction valued at approximately $48.7 billion, creating a global health and wellness leader.

Kimberly-Clark reports resilient third-quarter 2025 results with 2.5% organic sales growth driven by innovation and volume, while updating its full-year outlook.

Kimberly-Clark announced robust second quarter 2025 results, driven by innovation-led volume growth and effective cost management, leading to an upward revision of its full-year outlook.

Kimberly-Clark Corporation has reclassified its International Family Care and Professional segment as discontinued operations, providing supplemental historical financial data to reflect its strategic joint venture with Suzano S.A.

Kimberly-Clark announced a strategic partnership with Suzano S.A. to form a joint venture for its International Family Care and Professional (IFP) business, receiving approximately $1.7 billion for a 51% stake and sharpening its focus on higher-growth segments.

Kimberly-Clark Corporation will voluntarily transfer its U.S. stock exchange listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market (Nasdaq), effective May 30, 2025.

Kimberly-Clark Corporation discloses long-term incentive awards and compensation details for Andrew Scribner, the newly elected Vice President and Controller, effective June 1, 2025.

Kimberly-Clark Corporation has promoted Russ Torres to President and Chief Operating Officer, effective May 1, 2025, to oversee day-to-day operations and drive global growth.

Kimberly-Clark Corporation held its 2025 Annual Meeting of Stockholders on May 1, 2025, where stockholders elected directors, ratified the selection of Deloitte & Touche LLP as independent auditors, and approved executive compensation.

Kimberly-Clark reports a decrease in net sales for Q1 2025, adjusting its full-year outlook due to potential incremental costs from a more uncertain geopolitical landscape.

Kimberly-Clark Corporation has appointed Andrew Scribner as its new Vice President and Controller, effective June 1, 2025, succeeding Andrew S. Drexler who will retire shortly after.

Kimberly-Clark reported strong 2024 results, exceeding their long-term growth algorithm and establishing a foundation for their Powering Care strategy, with a positive outlook for continued growth in 2025.

Kimberly-Clark Corporation has reorganized its internal structure, shifting from product-based to geographic-based reporting segments to streamline its supply chain and improve efficiency.

Kimberly-Clark Corporation has elected Joseph Romanelli, President of Human Health International for Merck & Co., to its Board of Directors, effective immediately, increasing the board size to thirteen.

Kimberly-Clark's third quarter results show a 1% organic sales growth despite a 4% decrease in net sales, driven by strong in-market execution and cost management.

Kimberly-Clark reported strong second-quarter results, driven by organic sales growth and effective cost management, leading to an increased full-year earnings outlook.

Kimberly-Clark Corporation's stockholders approved an amended certificate of incorporation at the annual meeting, limiting certain officer liability and making technical changes.

Kimberly-Clark reported strong first-quarter 2024 results, driven by organic sales growth and productivity gains, leading to an increased full-year outlook.